Dexa Group Library

  • Home
  • Information
  • News
  • Help
  • Librarian
  • Member Area
  • Select Language :
    Arabic Bengali Brazilian Portuguese English Espanol German Indonesian Japanese Malay Persian Russian Thai Turkish Urdu

Search by :

ALL Author Subject ISBN/ISSN Advanced Search

Last search:

{{tmpObj[k].text}}

Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 11 from your keywords: subject="Starcef"
1 2 Next Last Page
cover
What Have We Learned From the Typhoid Fever Surveillance in Africa Program?
Comment Share
Baker S

The Typhoid Fever Surveillance in Africa Program (TSAP) was established in 2009 to fill the data void concerning invasive Salmonella disease in sub-Saharan Africa, and to specifically estimate the burden of bloodstream infections caused by the key pathogen, Salmonella enterica serovar Typhi. TSAP has achieved this ambitious target, finding high incidences of typhoid fever in both rural and u…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
MANAJEMEN TERAPI DEMAM TIFOID: KAJIAN TERAPI FARMAKOLOGIS DAN NON FARMAKOLOGIS
Comment Share
Rahmasari V

Demam tifoid adalah penyakit demam akut yang disebabkan oleh infeksi bakteri Salmonella typhi. Penderita demam tifoid di Indonesia mencapai 81% per 100.000. Demam tifoid dapat diberikan terapi farmakologis maupun non farmakologis yang bertujuan untuk mempercepat penyembuhan, meminimalkan komplikasi sekaligus untuk mencegah penyebaran penyakit. Metode yang digunakan dalam pengerjaan literatur r…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
Emerging insights into the biology of typhoid toxin
Comment Share
Fowler CC

Typhoid toxin is a unique A2B5 exotoxin and an important virulence factor for Salmonella Typhi, the cause of typhoid fever. In the decade since its initial discovery, great strides have been made in deciphering the unusual biological program of this toxin, which is fundamentally different from related toxins in many ways. Purified typhoid toxin administered to laboratory animals causes many of …

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
Penggunaan Antibiotik pada Terapi Demam Tifoid Anak di RSAB Harapan Kita
Comment Share
Adisasmito AW

Insidens demam tifoid di Indonesia cukup tinggi (>100 kasus per 100.000 populasi per tahun). Insidens pada anak usia 3-6 tahun adalah 1307 per 100.000 populasi per tahun, dan 1172 pada usia 7-19 tahun. Chloramphenicol sampai saat ini masih merupakan obat pilihan lini pertama untuk terapi demam tifoid pada anak. Antibiotik lain yang dipergunakan untuk terapi demam tifoid anak adalah cotrimoxazo…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
PENGGUNAAN ANTIBIOTIKA PADA PASIEN ANAK PENDERITA TIFUS ABDOMINALIS DI INSTAL…
Comment Share
Sapmaimy D

Tifus abdominalis merupakan penyakit infeksi sistemik dengan tingkat kematian yang signifikan terjadi hampir sepanjang tahun. Penyakit ini masih merupakan permasalahan kesehatan umum yang terjadi di negara-negara berkembang, terutama pada anak-anak di Indonesia. Tujuan penelitian ini adalah untuk mengetahui penggunaan antibiotika pada pasien anak penderita tifus abdominalis di instalasi rawat …

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
Typhoid fever: issues in laboratory detection, treatment options & concerns i…
Comment Share
Veeraraghavan B

Multidrug-resistant Salmonella enterica subsp. enterica serovar Typhi (resistant to ampicillin, chloramphenicol and cotrimoxazole), was significantly reduced with the increased usage of fluoroquinolones and azithromycin. This has led to declining multidrug resistance rates in Indiawith increasing ciprofloxacin nonsusceptibility rates and clinical failures due to azithromycin. However, for the …

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
CEFIXIME: A PHARMACOECONOMIC PERSPECTIVE
Comment Share
QUINTILIANI R

Cefixime, the first oral third-generation cephalosporin available, is commonly used for the treatment of upper and lower respiratory tract infections, otitis media, sinusitis, urinary tract infections, and gonorrhea. The drug has a number of characteristics that make it effective when administered once or twice daily: a half-life of 3 to 4 hours, activity against most common pathogens involved …

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
Double-Blind Study Comparing 3-Day Regimens of Cefixime and Ofloxacin in Trea…
Comment Share
RAZ, R

This double-blind randomized study compared 3-day regimens of cefixime (400 mg once daily) and ofloxacin (200 mg twice a day) in the treatment of urinary tract infections in women. The respective clinical cure rates for the two groups of women were 89 and 92% after 7 days and 81 and 84% after 4 weeks. The respective microbiological cure rates (free of bacteriuria) for the two groups of women we…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of S…
Comment Share
Dabernat H

A multicentre, open-label, randomized study was performed in 501 out-patients with acute otitis media, aged 6–36 months, to study the impact of treatment with either cefixime suspension 8 mg/kg/day bd or co-amoxiclav suspension 80 mg/kg/day tds for 10 days on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae. Of 426 patients with nasopharyngeal cultures at entry …

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
Cefixime: a review of its antibacterial activity, pharmacokinetic properties …
Comment Share
Brodgen RN

Cefixime, previously designated FK027, FR17027 and CL284635, is an orally active cephalosporin with a broad spectrum of antibacterial activity in vitro. It is particularly active against many Enterobacteriaceae, Haemophilus influenzae. Streptococcus pyogenes, Streptococcus pneumoniae and Branhamella catarrhalis, and is resistant to hydrolysis by many beta-lactamases. Cefixime has little activit…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
1 2 Next Last Page
Dexa Group Library
  • Information
  • Services
  • Librarian
  • Member Area

About Us

This digital catalog is dedicated to all members of DEXAN as part of our ongoing effort to provide practical, effective, efficient, up-to-date, and comprehensive information services that can be accessed anytime and anywhere.We have developed this website as a medium for information sharing and user interaction. We are committed to continuous innovation in order to become a reliable source of information that meets the evolving needs of DEXAN. Our mission includes supporting literacy culture enhancement programs and improving service quality.Inspired by the concept of The Dynamic Library, we are constantly evolving to optimize our role in supporting and facilitating research, education, preservation, information, and recreation—while striving to deliver excellent service.This platform also offers a guide on how to independently access information through this digital catalog.

Search

start it by typing one or more keywords for title, author or subject

Keep SLiMS Alive Want to Contribute?

© 2026 — Senayan Developer Community

Powered by SLiMS
Select the topic you are interested in
  • Computer Science, Information & General Works
  • Philosophy & Psychology
  • Religion
  • Social Sciences
  • Language
  • Pure Science
  • Applied Sciences
  • Art & Recreation
  • Literature
  • History & Geography
Icons made by Freepik from www.flaticon.com
Advanced Search
Where do you want to share?